may assist pseudoprogression interpretation, while RECIST maintains superiority in standardization, regulatory acceptance, and spatial resolution. Based on these complementary characteristics, we propose a ctDNA-enhanced RECIST framework (C) , in which ctDNA serves as an adjunct across three clinical scenarios: early e...
Jian-Shan Zheng, Lui Chi, Yong Guo· Frontiers in Oncology· 0 citations
Pretreatment HRQoL provides multidimensional prognostic information, with Global QoL and physical, role, emotional, and social functioning showing the most consistent evidence, and these domains may help prioritize pretreatment supportive-care assessment.
Yu-Jie Hu, Qing-Fei Chu, Meng-Jia Lin et al.· The Laryngoscope· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.